LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance' [Yahoo! Finance]
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: Yahoo! Finance
And year after year it's been, by-and-large, a losing bet. Most Read from Bloomberg London Insurers Face Baltimore Bridge Payouts Worth Billions Biden Gains Ground Against Trump in Six Key States, Poll Shows Japan Amps Up Intervention Threat as Yen Hits Lowest Since 1990 Trump's Net Worth Hits $6.5 Billion, Making Him One of World's 500 Richest People China Property Crisis Is Rippling Through Its Biggest Banks Now, three months into 2024, investors are once again piling in. Shares of Mind Medicine Inc., or MindMed, have more than doubled this year, while GH Research Plc's stock price has surged by roughly 85%. Billionaire-backed Atai Life Sciences NV has climbed more than 25%. It's easy to dismiss the gains as another false dawn in a sector that's had plenty of them. Yet some of the $15 billion market's most ardent observers say this time could really be different. For one, MindMed's LSD-based treatment for anxiety became just the third drug in the psychedelic spac
Show less
Read more
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- MindMed to Present at Upcoming May Medical ConferencesBusiness Wire
- This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher [Yahoo! Finance]Yahoo! Finance
- Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' [Yahoo! Finance]Yahoo! Finance
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.MarketBeat
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $20.00 price target on the stock.MarketBeat
MNMD
Earnings
- 11/2/23 - Beat
MNMD
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- MNMD's page on the SEC website